|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Experience with oral contraceptives. |
| Antiseptic 65(1): 843-846. November 1968. |
| The Indian Contraceptive Testing Unit started making field trials with oral contraceptives in 1964. By June 1968, 958 |
| women were taking oral contraceptives. Combination tablets used contained a minimum amount of progestogen (.5-3 |
| mg) and a suitable amount of estrogen. The 21-tablet pack was found mot suitable. It was found that if a woman |
| missed taking the tablets in the latter half of the cycle usually no harm resulted, but if she missed them at the |
| beginning of the cycle pregnancy might follow as ovulation would not be inhibited. Main contraindications are liver |
| damage, toxic hyperthyroidism, thromboembolic disease, and cancer of the genital tract or breast. Caution is advised |
| for persons with chronic nephritis, a history of eclampsia, hypertension, varicose veins, ophthalmological disorders, |
| or psychic depressive states. Side effects have been less with the smaller doses. The most serious side effect is |
| thromboembolism. Those reported have been leg pain, giddiness, headache, breakthrough bleeding, nausea, |
| vomiting, amenorrhea, abdominal pain, weakness, increased blood pressure, and skin rashes. Others have reported |
| ocular disease and cranial nerve palsy. Sequential therapy has been reported to have a lower incidence of side |
| effects but a higher rate of pregnancy. Low-dose progestogen therapy, the "minipill," does not inhibit ovulation but is |
| effective by causing changes in the endometrium and in the mucus. The chlormadinone in the minipill does not |
| affect lactation. However, the incidence of pregnancy is similar to that with an IUD (Lippes loop) which is 2.6/100 |
| cases. Laboratory tests have been normal, except an increase in the thymol turbidity test. Vaginal cytology has |
| revealed no case of malignancy. Results show that oral contraceptives are suitable for use on a mass scale as a |
| method of population control. (PubHealth.info Document ID: CONT9T 1024-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Experience with oral contraceptives.", is(are) Virkar KD. |
| The source of this article is "Antiseptic 65(1): 843-846. November 1968.". This article was published in 1968 in |
| English language(s). (PubHealth.info® Document ID: CONT9T 1024-06. All rights reserved with PubHealth.info) PIN: |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
